Rights and permissions
About this article
Cite this article
There appears to be no additional benefit of continuing adjuvant tamoxifen therapy beyond 5 years. Inpharma Wkly. 1287, 19 (2001). https://doi.org/10.2165/00128413-200112870-00051
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200112870-00051